Group Cognitive Therapy and Alprazolam in the Treatment of Depression in Older Adults

Larry E. Beutler, Forrest Scogin, Patricia Kirkish, David Schretlen, Anne Corbishley, David Hamblin, Keith Meredith, Rebecca Potter, Colin R Bamford, Alan I. Levenson

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

This study was designed to explore the relative and combined effectiveness of alprazolam (Xanax) and group cognitive therapy among elderly adults experiencing major affective disorder. Fifty-six subjects with Diagnostic and Statistical Manual of Mental Disorders (DSM-III;American Psychiatric Association, 1980) diagnoses of major, unipolar depression were treated over a 20-week period in one of four groups: alprazolam support, placebo support, cognitive therapy plus placebo support, and cognitive therapy plus alprazolam support. The results revealed that individuals assigned to group cognitive therapy showed consistent improvement in subjective state and sleep efficiency relative to non-group-therapy subjects. No differences between alprazolam and placebo were noted, regardless of whether individuals received group cognitive therapy. Subjects assigned to group cognitive therapy were less likely than their counterparts to prematurely terminate treatment.

Original languageEnglish (US)
Pages (from-to)550-556
Number of pages7
JournalJournal of Consulting and Clinical Psychology
Volume55
Issue number4
StatePublished - Aug 1987

Fingerprint

Alprazolam
Cognitive Therapy
Group Psychotherapy
Depression
Placebos
Diagnostic and Statistical Manual of Mental Disorders
Therapeutics
Depressive Disorder
Mood Disorders
Sleep

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Beutler, L. E., Scogin, F., Kirkish, P., Schretlen, D., Corbishley, A., Hamblin, D., ... Levenson, A. I. (1987). Group Cognitive Therapy and Alprazolam in the Treatment of Depression in Older Adults. Journal of Consulting and Clinical Psychology, 55(4), 550-556.

Group Cognitive Therapy and Alprazolam in the Treatment of Depression in Older Adults. / Beutler, Larry E.; Scogin, Forrest; Kirkish, Patricia; Schretlen, David; Corbishley, Anne; Hamblin, David; Meredith, Keith; Potter, Rebecca; Bamford, Colin R; Levenson, Alan I.

In: Journal of Consulting and Clinical Psychology, Vol. 55, No. 4, 08.1987, p. 550-556.

Research output: Contribution to journalArticle

Beutler, LE, Scogin, F, Kirkish, P, Schretlen, D, Corbishley, A, Hamblin, D, Meredith, K, Potter, R, Bamford, CR & Levenson, AI 1987, 'Group Cognitive Therapy and Alprazolam in the Treatment of Depression in Older Adults', Journal of Consulting and Clinical Psychology, vol. 55, no. 4, pp. 550-556.
Beutler LE, Scogin F, Kirkish P, Schretlen D, Corbishley A, Hamblin D et al. Group Cognitive Therapy and Alprazolam in the Treatment of Depression in Older Adults. Journal of Consulting and Clinical Psychology. 1987 Aug;55(4):550-556.
Beutler, Larry E. ; Scogin, Forrest ; Kirkish, Patricia ; Schretlen, David ; Corbishley, Anne ; Hamblin, David ; Meredith, Keith ; Potter, Rebecca ; Bamford, Colin R ; Levenson, Alan I. / Group Cognitive Therapy and Alprazolam in the Treatment of Depression in Older Adults. In: Journal of Consulting and Clinical Psychology. 1987 ; Vol. 55, No. 4. pp. 550-556.
@article{275c8fde2f514a45ba99f0e52cf12f57,
title = "Group Cognitive Therapy and Alprazolam in the Treatment of Depression in Older Adults",
abstract = "This study was designed to explore the relative and combined effectiveness of alprazolam (Xanax) and group cognitive therapy among elderly adults experiencing major affective disorder. Fifty-six subjects with Diagnostic and Statistical Manual of Mental Disorders (DSM-III;American Psychiatric Association, 1980) diagnoses of major, unipolar depression were treated over a 20-week period in one of four groups: alprazolam support, placebo support, cognitive therapy plus placebo support, and cognitive therapy plus alprazolam support. The results revealed that individuals assigned to group cognitive therapy showed consistent improvement in subjective state and sleep efficiency relative to non-group-therapy subjects. No differences between alprazolam and placebo were noted, regardless of whether individuals received group cognitive therapy. Subjects assigned to group cognitive therapy were less likely than their counterparts to prematurely terminate treatment.",
author = "Beutler, {Larry E.} and Forrest Scogin and Patricia Kirkish and David Schretlen and Anne Corbishley and David Hamblin and Keith Meredith and Rebecca Potter and Bamford, {Colin R} and Levenson, {Alan I.}",
year = "1987",
month = "8",
language = "English (US)",
volume = "55",
pages = "550--556",
journal = "Journal of Consulting and Clinical Psychology",
issn = "0022-006X",
publisher = "American Psychological Association Inc.",
number = "4",

}

TY - JOUR

T1 - Group Cognitive Therapy and Alprazolam in the Treatment of Depression in Older Adults

AU - Beutler, Larry E.

AU - Scogin, Forrest

AU - Kirkish, Patricia

AU - Schretlen, David

AU - Corbishley, Anne

AU - Hamblin, David

AU - Meredith, Keith

AU - Potter, Rebecca

AU - Bamford, Colin R

AU - Levenson, Alan I.

PY - 1987/8

Y1 - 1987/8

N2 - This study was designed to explore the relative and combined effectiveness of alprazolam (Xanax) and group cognitive therapy among elderly adults experiencing major affective disorder. Fifty-six subjects with Diagnostic and Statistical Manual of Mental Disorders (DSM-III;American Psychiatric Association, 1980) diagnoses of major, unipolar depression were treated over a 20-week period in one of four groups: alprazolam support, placebo support, cognitive therapy plus placebo support, and cognitive therapy plus alprazolam support. The results revealed that individuals assigned to group cognitive therapy showed consistent improvement in subjective state and sleep efficiency relative to non-group-therapy subjects. No differences between alprazolam and placebo were noted, regardless of whether individuals received group cognitive therapy. Subjects assigned to group cognitive therapy were less likely than their counterparts to prematurely terminate treatment.

AB - This study was designed to explore the relative and combined effectiveness of alprazolam (Xanax) and group cognitive therapy among elderly adults experiencing major affective disorder. Fifty-six subjects with Diagnostic and Statistical Manual of Mental Disorders (DSM-III;American Psychiatric Association, 1980) diagnoses of major, unipolar depression were treated over a 20-week period in one of four groups: alprazolam support, placebo support, cognitive therapy plus placebo support, and cognitive therapy plus alprazolam support. The results revealed that individuals assigned to group cognitive therapy showed consistent improvement in subjective state and sleep efficiency relative to non-group-therapy subjects. No differences between alprazolam and placebo were noted, regardless of whether individuals received group cognitive therapy. Subjects assigned to group cognitive therapy were less likely than their counterparts to prematurely terminate treatment.

UR - http://www.scopus.com/inward/record.url?scp=0023502376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023502376&partnerID=8YFLogxK

M3 - Article

C2 - 3624611

AN - SCOPUS:0023502376

VL - 55

SP - 550

EP - 556

JO - Journal of Consulting and Clinical Psychology

JF - Journal of Consulting and Clinical Psychology

SN - 0022-006X

IS - 4

ER -